Anne-Laure Meynier
Investor Board Director
London, England, United Kingdom
12 investmentsAnne-Laure Meynier is an Investor Board Director based in London, England, United Kingdom. Anne-Laure Meynier has backed 12 companies, including Convergence Pharmaceuticals, Ulthera and Serentis. Investment focus areas include Health Care, Hospitals and Medical Testing.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (12)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | Convergence Pharmaceuticals | — | — | — | — |
| 2 | Ulthera | — | — | — | — |
| 3 | Serentis | — | — | — | — |
| 4 | NIMGenetics | — | — | — | — |
| 5 | Medical Imaging Partnership | — | — | — | — |
| 6 | Ambit Biosciences | — | — | — | — |
| 7 | PharmaKodex | — | — | — | — |
| 8 | Bird Rock Bio | — | — | — | — |
| 9 | Mirada Medical | — | — | — | — |
| 10 | Cancer Partners UK | — | — | — | — |
| 11 | Ambrx | — | — | — | — |
| 12 | Anaphore | — | — | — | — |
Showing 1–12 of 12
Access Full Contact Information
Get Anne-Laure Meynier's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.